I realize that I just wrote about infamous cancer doctor Stanislaw Burzynski yesterday. (Note how I refuse to call him an “oncologist,” mainly because he isn’t one, having never completed an oncology fellowship—or even an internal medicine residency, the usual prerequisite to do an oncology fellowship.) However, there’s a bit more that I wanted to […]
Category: Clinical trials
The year 2013 finished with serious setbacks for Stanislaw Burzynski and his unproven cancer treatment that he dubbed “antineoplastons” (ANPs) way back in the early 1970s. As you might recall, in November, two things happened. First, the FDA released its initial reports on its inspection of the Burzynski Clinic and Burzynski Research Institute (BRI) carried […]
Share this:
Practitioners of “complementary and alternative medicine” (CAM) have a love-hate relationship with randomized clinical trials (RCTs). Actually, it’s mostly hate, but they do crave the validation that only randomized clinical trials can provide within the paradigm of evidence-based medicine (EBM). Yes, I intentionally said EBM, rather than science-based medicine (SBM), because, as I’ve described so […]
Share this:
Here we go again. In the wake of study after study that fails to find activity of various “complementary and alternative medicine” (CAM) beyond that of placebo, the campaign to a “rebrand” CAM as “working” through the “power of placebo” continues apace, in the wake of the successful campaign to “rebrand” various needle-based medical modalities […]
Share this:
Well, that didn’t take long. I knew it had been too quiet on the Burzynski front. In retrospect, that was almost certainly because of the holidays, but the holidays are over, and real life is here again. Yes, the year 2014 is only a little more than a week old, and here comes Stanislaw Burzynski […]
